Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Novartis And China MOH Collaborate On Organ Donation Project

This article was originally published in PharmAsia News

Executive Summary

China's Ministry of Health's International Health Exchange and Cooperation Center and Novartis Foundation for People and the Environment have kicked off the second phase of China's first and largest collaborative international project on organ donation and transplant. The project, with a total funding of up to 20 billion yuan ($2.92 billion) will concentrate on organ transplant academic exchange, public education and publicity, a study on brain death, as well as R&D on living related transplantation. The Novartis foundation will invest 2 million Swiss francs in phase two of the project from 2008 to 2012. MOH will accelerate China's establishment of an organ transplant management system and seek out more international organizations and relevant parties to develop the program. (Click here for more - Chinese Language)

You may also be interested in...

China's Organ Donation System Overhauled

China's organ donation and transplant program will provide a platform for facilitating technology transfer and enhancing the establishment of the China Organ Donor System. The collaborative project between the Ministry of Health and Novartis was launched in 2003 to promote organ donation and transplant development in China (PharmAsia News, July 21, 2008). Last month, the program actively supported the Organ Transplantation Committee's meeting on organ donation mobilization, CODS establishment and trial initiation. A recent organ donation and transplant seminar discussed supplementary clauses for regulations on human organ transplantation; the program will strengthen live organ transplant standardization and set up an organ transplant data center. (Click here for more - Chinese Language)

Lilly Signs Deals With Dexcom, Glooko, myDiabby, Roche For Diabetes Management Solutions

Lilly announced it signed strategic international agreements with four diabetes companies to advance connected solutions and streamline care for people with diabetes in markets outside of the US.

Three IPOs, Three SPAC Mergers, But One Company Opted Out

Three firms launched initial public offerings during the first week of May, but Gyroscope postponed its IPO while Jasper, Science 37 and Roivant took the special purpose acquisition corporation route.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts